159 related articles for article (PubMed ID: 15105131)
1. Dose-dependent pharmacokinetics of itraconazole after intravenous or oral administration to rats: intestinal first-pass effect.
Shin JH; Choi KY; Kim YC; Lee MG
Antimicrob Agents Chemother; 2004 May; 48(5):1756-62. PubMed ID: 15105131
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
Shim HJ; Kim YC; Park KJ; Kim DS; Kwon JW; Kim WB; Lee MG
J Pharm Sci; 2003 Nov; 92(11):2185-95. PubMed ID: 14603504
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects.
Kim SH; Lee MG
Life Sci; 2002 Feb; 70(11):1299-315. PubMed ID: 11883708
[TBL] [Abstract][Full Text] [Related]
4. Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects.
Choi YH; Kim SG; Lee MG
J Pharm Sci; 2006 Nov; 95(11):2543-52. PubMed ID: 16937336
[TBL] [Abstract][Full Text] [Related]
5. Hepatic and intestinal first-pass effects of oltipraz in rats.
Bae SK; Kim JW; Kim YH; Kim YG; Kim SG; Lee MG
Biopharm Drug Dispos; 2005 May; 26(4):129-34. PubMed ID: 15744718
[TBL] [Abstract][Full Text] [Related]
6. Dose-independent pharmacokinetics of a candidate for diabetic neuropathy, SR-4668, after intravenous and oral administration to rats: Intestinal first-pass effect.
Kim EJ; Bae SK; Kim HJ; Kim YG; Kim SO; Lee DH; Lim H; Lee MG
J Pharm Sci; 2003 May; 92(5):1112-24. PubMed ID: 12712431
[TBL] [Abstract][Full Text] [Related]
7. Dose-independent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
Lee MH; Bae SK; Kim EJ; Kim YG; Kim SO; Lee DH; Lim H; Yoo SE; Lee MG
J Pharm Sci; 2003 Jan; 92(1):190-201. PubMed ID: 12486695
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
Han KS; Lee MG
Drug Metab Dispos; 1999 Feb; 27(2):221-6. PubMed ID: 9929506
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effects.
Shin HS; Bae SK; Lee MG
Int J Pharm; 2006 Aug; 320(1-2):64-70. PubMed ID: 16730145
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal first-pass effect of YJA-20379-8, a new reversible proton pump inhibitor, in rats.
Kim J; Kim EJ; Han KS; Chang MS; Lee MG
J Pharm Pharmacol; 1999 Sep; 51(9):1031-6. PubMed ID: 10528986
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of DA-7867, a new oxazolidinone, after intravenous or oral administration to rats: intestinal first-pass effect.
Bae SK; Chung WS; Kim EJ; Rhee JK; Kwon JW; Kim WB; Lee MG
Antimicrob Agents Chemother; 2004 Feb; 48(2):659-62. PubMed ID: 14742232
[TBL] [Abstract][Full Text] [Related]
12. Dose-independent pharmacokinetics of a new reversible proton pump inhibitor, KR-60436, after intravenous and oral administration to rats: gastrointestinal first-pass effect.
Yu SY; Bae SK; Kim EJ; Kim YG; Kim SO; Lee DH; Lim H; Lee MG
J Pharm Sci; 2003 Aug; 92(8):1592-603. PubMed ID: 12884246
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent pharmacokinetics of a new reversible proton pump inhibitor, DBM-819, after intravenous and oral administration to rats: hepatic first-pass effect.
Kim EJ; Kim SO; Lee DH; Lim H; Lee MG
Biopharm Drug Dispos; 2001 Apr; 22(3):119-28. PubMed ID: 11745914
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent pharmacokinetics of telithromycin after intravenous and oral administration to rats: contribution of intestinal first-pass effect to low bioavailability.
Lee JH; Lee MG
J Pharm Pharm Sci; 2007; 10(1):37-50. PubMed ID: 17498392
[TBL] [Abstract][Full Text] [Related]
15. Intestinal first-pass effect of bumetanide in rats.
Kim EJ; Han KS; Lee MG
Int J Pharm; 2000 Jan; 194(2):193-9. PubMed ID: 10692643
[TBL] [Abstract][Full Text] [Related]
16. Dose-Dependent Pharmacokinetics of Tofacitinib in Rats: Influence of Hepatic and Intestinal First-Pass Metabolism.
Lee JS; Kim SH
Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31284540
[TBL] [Abstract][Full Text] [Related]
17. Dose-independent pharmacokinetics of clindamycin after intravenous and oral administration to rats: contribution of gastric first-pass effect to low bioavailability.
Yang SH; Lee MG
Int J Pharm; 2007 Mar; 332(1-2):17-23. PubMed ID: 17157458
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of a new reversible proton pump inhibitor, YH1885, after intravenous and oral administrations to rats and dogs: hepatic first-pass effect in rats.
Han KS; Kim YG; Yoo JK; Lee JW; Lee MG
Biopharm Drug Dispos; 1998 Nov; 19(8):493-500. PubMed ID: 9840211
[TBL] [Abstract][Full Text] [Related]
19. Absorption, first-pass metabolism, and disposition of itraconazole in rats.
Yoo SD; Kang E; Jun H; Shin BS; Lee KC; Lee KH
Chem Pharm Bull (Tokyo); 2000 Jun; 48(6):798-801. PubMed ID: 10866139
[TBL] [Abstract][Full Text] [Related]
20. Liver and gastrointestinal first-pass effects of azosemide in rats.
Kim J; Kim SH; Lee MG
J Pharm Pharmacol; 1997 Sep; 49(9):878-83. PubMed ID: 9306255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]